Discovery of potent, selective, and orally bioavailable GSPT1 degraders and their preclinical anti-tumor activity in acute myeloid leukemia and solid tumors

被引：0
|
作者：
Joo, Min Sung
Lee, JaeYung
Kim, Eun-Jung
Ki, Dong Hyuk
Choi, Hunmi
Nam, Joonwoo
Park, Jaewoo
Kang, Keon Wook
Han, Wooseok
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1673
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1673
引用
收藏
页数：2
相关论文
共 50 条
  • [11] HJM-353: A potent, selective and orally bioavailable EED inhibitor with robust anti-tumor activities
    Ma, X.
    Qi, W.
    Du, Y.
    Kong, D.
    Geng, Y.
    Zeng, L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1122 - S1122
  • [12] Structure-Activity Relationship of Potent, Selective, and Orally Bioavailable Molecular Glue Degraders of CK1α
    Nishiguchi, Gisele
    Caine, Elizabeth A.
    Mcgowan, Kevin
    Shi, Zhe
    Aggarwal, Anup
    Mayasundari, Anand
    Price, Jeanine
    Yang, Lei
    Li, Yong
    Fu, Xiang
    Mascibroda, Lauren G.
    Das, Sourav
    Daniels, Danette L.
    Urh, Marjeta
    Klco, Jeffery M.
    Riching, Kristin M.
    Rankovic, Zoran
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (10): : 1692 - 1698
  • [13] Discovery of novel, potent, and orally bioavailable HDACs inhibitors with LSD1 inhibitory activity for the treatment of solid tumors
    Duan, Yingchao
    Yu, Tong
    Jin, Linfeng
    Zhang, Shaojie
    Shi, Xiaojing
    Zhang, Yizhe
    Zhou, Nanqian
    Xu, Yongtao
    Lu, Wenfeng
    Zhou, Huimin
    Zhu, Huijuan
    Bai, Suping
    Hu, Kua
    Guan, Yuanyuan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 254
  • [14] Synergistic Combination Activity of the Novel GSPT1 Degrader CC-90009 in Acute Myeloid Leukemia Models
    Pierce, Daniel W.
    Yao, Tsun-Wen Sheena
    Yao, Sheena
    Pace, Emily
    Wang, Hongbin
    Flandin-Blety, Pierre
    Benitez, Alicia
    Guarinos, Carla
    Hoffmann, Matthew
    Carrancio, Soraya
    Fan, Jonhong
    Pourdehnad, Michael
    BLOOD, 2021, 138
  • [15] Identification and preclinical characterization of NMS-P626, a potent, selective and orally bioavailable TrkA inhibitor with anti-tumor activity in a TrkA-dependent colorectal cancer
    Ardini, E.
    Borgia, A. Lombardi
    De Ponti, C.
    Amboldi, N.
    Ballinari, D.
    Saccardo, M. B.
    Magnaghi, P.
    Pesenti, E.
    Isacchi, A.
    Galvani, A.
    EJC SUPPLEMENTS, 2010, 8 (07): : 39 - 40
  • [16] Discovery of potent and selective CK1α molecular degrader with a favorable safety profile for acute myeloid leukemia and solid tumors
    Kong, Jinuk
    Park, Jisu
    Lee, Heekyu
    Kang, Hyunseok
    Lee, Deokjae
    Jo, Hyunsun
    CANCER RESEARCH, 2023, 83 (07)
  • [17] Discovery of INCB9471, a Potent, Selective, and Orally Bioavailable CCR5 Antagonist with Potent Anti-HIV-1 Activity
    Xue, Chu-Biao
    Chen, Lihua
    Cao, Ganfeng
    Zhang, Ke
    Wang, Anlai
    Meloni, David
    Glenn, Joseph
    Anand, Rajan
    Xia, Michael
    Kong, Ling
    Huang, Taisheng
    Feng, Hao
    Zheng, Changsheng
    Li, Mei
    Galya, Laurine
    Zhou, Jiacheng
    Shin, Niu
    Baribaud, Fredric
    Solomon, Kim
    Scherle, Peggy
    Zhao, Bitao
    Diamond, Sharon
    Emm, Tom
    Keller, Douglas
    Contel, Nancy
    Yeleswaram, Swamy
    Vaddi, Kris
    Hollis, Gregory
    Newton, Robert
    Friedman, Steven
    Metcalf, Brian
    ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (09): : 483 - 487
  • [18] Discovery of a potent and selective PARP1 inhibitor and trapper with anti-tumor activities in HRD tumors
    Gao, Mingming
    Li, Zhentian
    Fan, Qipeng
    Pan, Jun
    Bai, Yu
    Zhang, Hewen
    Li, Yu
    Wu, Yongzhong
    Liu, Phillip C. C.
    Wu, Liangxing
    Yao, Wenqing
    Wang, Hui
    CANCER RESEARCH, 2023, 83 (07)
  • [19] BTX-1188, a first-in-class dual degrader of GSPT1 and IKZF1/3, for treatment of acute myeloid leukemia (AML) and solid tumors.
    Chourasia, Aparajita Hoskote
    Majeski, Hannah
    Pasis, Angela
    Erdman, Paul
    Oke, Ashwini
    Hecht, David
    Lonergan, David
    Mercurio, Frank
    Chan, Kyle
    Thai, Dung Luong
    Fung, Leah
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [20] Anti-Tumor Effects of BDH1 in Acute Myeloid Leukemia
    Han, Fei
    Zhao, Huanhuan
    Lu, Jun
    Yun, Weina
    Yang, Lingling
    Lou, Yude
    Su, Dan
    Chen, Xin
    Zhang, Shixuan
    Jin, Hanwei
    Li, Xiang
    Sun, Jie
    Huang, He
    Wang, Qishan
    Jiang, Xi
    FRONTIERS IN ONCOLOGY, 2021, 11
12345